Wednesday, September 23, 2020
wellness India Expo
Home Tags Durvalumab

Tag: Durvalumab

AstraZeneca receives marketing permission for Durvalumab (ImfinziTM) in India

Durvalumab is the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) and was granted US FDA ‘breakthrough therapy’ designation on July 31, 2017.....................